Idera Pharmaceuticals Inc (NASDAQ: IDRA) is having an incredibly strong start to the trading session this morning, and for good reason. The company updated investors with regard to the company’s strategy this morning, following the news surrounding the termination of the proposed merger with BioCryst Pharmaceuticals. Today, we’ll talk about: The update; what we’re seeing … Read more
Idera Pharmaceuticals Inc (NASDAQ: IDRA) is having an overwhelmingly rough start to the trading session this mroning after the company announced top-line data from a Phase 2 clinical trial. Unfortunatley, the trial proved to be a failure, leading to fear among investors and sending the stock spiraling downward. Today, we’ll talk about: The clinical results; … Read more
Idera Pharmaceuticals (NASDAQ: IDRA) is a very interesting stock to watch. As far as price action goes, the value of the stock has seen some pretty dramatic rises and falls over the past year. However, the actual movement at the end here is pretty minimum. Today, the stock trades at $1.97 per share. That’s only a … Read more
Idera Pharmaceuticals Inc (NASDAQ: IDRA) is having an overwhelmingly strong day in the market today, and for good reason. The company issued a press release this morning, providing investors with an update with regard to both clinical development and corporate activities. Today, we’ll talk about the update, what we’re seeing from the stock, and what … Read more
Idera Pharmaceuticals Inc (NASDAQ: IDRA) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that it has received Fast Track Designation from the United States Food and Drug Association. Today, we’ll talk about the news, how the stock reacted, and what we’ll be watching for … Read more
Idera Pharmaceuticals Inc (NASDAQ: IDRA) is having an incredibly strong start to the trading session this morning after announcing strong Phase 1/2 clinical data. Of course, our partners at Trade Ideas were the first to alert us to the gains. At the moment (9:55), IDRA is trading at $2.22 per share after a gain of … Read more
Idera Pharmaceuticals Inc (NASDAQ: IDRA) is having an incredible start to the trading session today, and for good reason. The company provided an update with regard to one of the therapies that it is currently investigating, leading to excitement among investors and gains in the stock. As is almost always the case, our partners at … Read more
Idera Pharmaceuticals Inc (NASDAQ: IDRA) Idera Pharmaceuticals is having an incredible day in the market today. The movement in the stock is driven by news that JPM securities has initiated coverage on the stock, and they have a positive view overall. As a result of the news, the stock spiked, causing our partners at Trade … Read more
Looking into the biotech market today, things aren’t looking too great. Nonetheless, there are still several opportunities that are popping up. Today, we’ll talk about 3 stocks I’ve found in biotech that seem to be presenting strong opportunities for growth. So, let’s get right to it… Idera Pharmaceuticals Stock Climbs On New Coverage Idera Pharmaceuticals … Read more
On Friday, in the course of current trade, Shares of Dollar General Corp. (NYSE:DG), dropped -0.48%, and is now trading at $72.75. Dollar General, declared that the Company’s Board of Directors has declared a regular quarterly cash dividend of $0.22 per share on the Company’s common stock. The dividend will be payable on July 1, … Read more